TransCode Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. Its lead product candidate is TTX-MC138, an antisense inhibitor of an oncogenic microRNA. 

CEO
Philippe P. Calais
CEOPhilippe P. Calais
Employees
12
Employees12
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
12
Employees12

RNAZ Key Statistics

Market cap
5.64M
Market cap5.64M
Price-Earnings ratio
-0.12
Price-Earnings ratio-0.12
Dividend yield
Dividend yield
Average volume
13.68K
Average volume13.68K
High today
High today
Low today
Low today
Open price
$6.45
Open price$6.45
Volume
0.00
Volume0.00
52 Week high
$20.99
52 Week high$20.99
52 Week low
$3.82
52 Week low$3.82

Stock Snapshot

As of today, TransCode Therapeutics(RNAZ) shares are valued at $5.93. The company's market cap stands at 5.64M, with a P/E ratio of -0.12.

During the trading day, TransCode Therapeutics(RNAZ) stock saw an opening price of $6.45, a peak of —, and a bottom of —.

Trading volume for TransCode Therapeutics(RNAZ) stock has reached 0, versus its average volume of 13.68K.

Over the past 52 weeks, TransCode Therapeutics(RNAZ) stock has traded between a high of $20.99 and a low of $3.82.

Over the past 52 weeks, TransCode Therapeutics(RNAZ) stock has traded between a high of $20.99 and a low of $3.82.

RNAZ News

TipRanks 7d
TransCode Therapeutics Shareholders Approve Key Capital Measures

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own RNAZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.